Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for DBA2J Phosphatidylethanolamine Analysis (Study ST000579)

Other NEGATIVE ION MODE (Analysis AN000890)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8
PE(20:0/18:4(6Z,9Z,12Z,15Z))	ME169855	0.04	11.88	0.23	0.88	0.35	0.34	0.25	0.11
PE(21:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME169863	0.19	6.90	0.97	1.07	0.76	0.41	0.37	0.32
PE(17:0/20:0)	ME169843	0.10	8.52	0.06	0.64	0.23	0.68	0.89	0.56
PE(17:0/22:4(7Z,10Z,13Z,16Z))	ME169847	0.04	7.83	0.23	NA	0.47	0.40	0.56	0.28
PE(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME169852	0.02	4.35	NA	0.27	0.79	1.19	0.65	1.02
PE(20:0/22:1(13Z))	ME169881	NA	3.78	NA	0.08	0.08	0.07	0.06	0.07
PE(20:0/22:2(13Z,16Z))	ME169889	0.34	4.45	0.24	0.17	0.82	NA	0.16	NA
PE(21:0/22:2(13Z,16Z))	ME169883	0.03	4.96	0.74	NA	0.28	0.33	NA	0.33
PE(20:0/22:4(7Z,10Z,13Z,16Z))	ME169858	0.13	5.29	1.23	0.70	0.71	0.66	0.32	1.31
PE(20:0/20:2(11Z,14Z))	ME169856	1.61	5.49	0.89	1.24	0.33	0.40	0.51	0.11
PE(18:0/20:0)	ME169850	0.05	4.76	1.06	1.47	0.69	0.74	0.71	0.17
PE(18:1(9Z)/22:2(13Z,16Z))	ME169879	0.03	5.49	NA	0.71	0.27	0.48	0.69	0.37
PE(18:0/18:0)	ME169848	0.31	5.50	0.07	1.46	0.40	NA	0.72	0.32
PE(20:5(5Z,8Z,11Z,14Z,17Z)/22:5(7Z,10Z,13Z,16Z,19Z))	ME169860	0.03	5.64	0.61	1.20	0.62	0.25	0.17	0.28
PE(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME169842	0.17	5.64	0.67	2.35	0.26	0.22	0.70	0.23
NAPE(18:1(9Z)/16:1(9Z)/18:0)	ME169838	0.07	4.79	0.13	1.55	0.10	NA	0.16	0.33
PE(22:0/22:4(7Z,10Z,13Z,16Z))	ME169865	0.02	5.02	NA	2.26	0.51	0.10	0.42	0.05
PE(16:0/18:1(9Z))	ME169900	0.06	NA	2.76	NA	NA	0.76	0.66	NA
PE(19:0/22:4(7Z,10Z,13Z,16Z))	ME169880	0.08	NA	2.76	NA	0.84	0.59	0.07	0.30
PE(18:0/18:1(9Z))	ME169849	0.95	NA	NA	1.61	0.44	1.22	0.76	0.24
PE(21:0/22:1(11Z))	ME169862	0.61	NA	0.10	2.15	0.58	0.65	1.15	1.01
PE(20:0/24:1(15Z))	ME169882	0.21	NA	1.25	NA	0.65	2.43	NA	0.22
PE-NMe2(16:0/16:0)	ME169870	NA	NA	NA	0.02	0.79	2.19	1.21	0.31
PE(16:0/20:4(5Z,8Z,11Z,14Z))	ME169841	NA	NA	NA	0.15	0.27	1.95	0.50	1.18
PE-NMe(16:0/18:1(9Z))	ME169886	0.05	NA	NA	NA	NA	1.92	0.62	0.87
PE(13:0/22:4(7Z,10Z,13Z,16Z))	ME169840	NA	NA	NA	NA	1.21	0.95	1.16	0.46
PE(16:0/16:0)	ME169899	NA	NA	NA	0.08	1.85	1.41	0.25	NA
PE(13:0/20:1(11Z))	ME169871	NA	NA	NA	NA	0.04	0.33	3.05	0.58
PE(20:2(5Z,8Z)/18:0)	ME169859	0.02	2.22	NA	0.58	1.41	0.49	1.64	0.57
PE(26:2(5Z,9Z)/26:2(5Z,9Z))	ME169869	3.75	0.83	0.24	3.28	0.29	NA	0.17	0.13
PE(18:0/22:0)	ME169851	2.96	2.02	0.24	0.77	0.36	0.18	0.36	0.36
PE(21:0/22:0)	ME169861	2.51	2.96	0.09	1.12	0.26	0.23	1.44	0.15
PE(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))	ME169867	NA	NA	NA	3.55	NA	0.24	0.09	0.12
PE-NMe(18:1(9E)/18:1(9E))	ME169890	0.08	NA	0.09	3.73	0.85	0.30	0.10	NA
PE(17:0/22:0)	ME169876	0.08	NA	NA	4.45	1.00	0.91	0.52	0.01
PE(17:0/22:2(13Z,16Z))	ME169846	NA	NA	NA	4.66	0.33	0.25	0.18	0.29
PE(22:0/22:2(13Z,16Z))	ME169864	0.12	NA	1.69	4.45	0.14	0.01	0.54	0.18
PE(24:0/20:0)	ME169868	0.02	0.55	1.38	3.24	0.69	0.70	0.25	0.46
PE(22:0/24:1(15Z))	ME169866	0.23	3.19	0.28	5.38	0.14	0.16	0.53	0.33
PE(17:0/20:4(5Z,8Z,11Z,14Z))	ME169844	1.03	2.57	0.40	3.37	0.43	0.20	1.20	0.17
PE(20:0/22:0)	ME169857	0.01	3.90	0.41	3.59	0.21	0.21	0.16	0.12
PE-NMe(20:0/20:0)	ME169887	0.12	4.09	1.23	2.78	0.38	0.37	0.29	0.22

Factors:

F1	Tissue Location:AH \| Sex:Female \| Phenotype:Hypertensive
F2	Tissue Location:AH \| Sex:Female \| Phenotype:Normotensive
F3	Tissue Location:AH \| Sex:Male \| Phenotype:Hypertensive
F4	Tissue Location:AH \| Sex:Male \| Phenotype:Normotensive
F5	Tissue Location:TM \| Sex:Female \| Phenotype:Hypertensive
F6	Tissue Location:TM \| Sex:Female \| Phenotype:Normotensive
F7	Tissue Location:TM \| Sex:Male \| Phenotype:Hypertensive
F8	Tissue Location:TM \| Sex:Male \| Phenotype:Normotensive

Data matrix